- Trials with a EudraCT protocol (167)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
167 result(s) found for: Liraglutide.
Displaying page 1 of 9.
EudraCT Number: 2010-018619-14 | Sponsor Protocol Number: Lira-Vasc-001 | Start Date*: 2010-03-31 |
Sponsor Name:ikfe GmbH | ||
Full Title: Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus | ||
Medical condition: Type 2 Diabetes Mellitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003298-40 | Sponsor Protocol Number: SCALES | Start Date*: 2014-12-15 |
Sponsor Name:Instituto de Investigación La Fe | ||
Full Title: STUDY OF THE EFFICACY AND SAFETY MANAGEMENT OF LIRAGLUTIDE IN TYPE 2 DIABETIC PATIENTS HOSPITALIZED WITH ACUTE CORONARY SYNDROME. IMPACT ON CARDIOVASCULAR RISK FACTOR. | ||
Medical condition: TYPE 2 DIABETIC HOSPITALIZED PATIENTS WITH ACUTE CORONARY SYNDROME. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001949-13 | Sponsor Protocol Number: LIRHV | Start Date*: 2019-01-31 | |||||||||||
Sponsor Name:KU Leuven | |||||||||||||
Full Title: The effect of liraglutide on MMC activity, gastrointestinal hormones, hunger ratings and ad libitum food intake in healthy volunteers | |||||||||||||
Medical condition: The study will focus on the underlying mechanisms of obesity. The effects will first be investigated in healthy, lean volunteers. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005344-95 | Sponsor Protocol Number: 3004 | Start Date*: 2012-06-15 |
Sponsor Name:Steno Diabetes Center | ||
Full Title: Time course of the blood pressure lowering effect of liraglutide therapy in type 2 diabetes | ||
Medical condition: type 2 diabetes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000238-43 | Sponsor Protocol Number: LI20/1101 | Start Date*: 2014-05-13 | |||||||||||
Sponsor Name:University of Tartu | |||||||||||||
Full Title: Effect of repeated administration of liraglutide on insulinogenic indices. | |||||||||||||
Medical condition: Healthy volunteers (Type 2. diabetes mellitus). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023226-20 | Sponsor Protocol Number: S52711 | Start Date*: 2010-11-24 |
Sponsor Name:KULeuven | ||
Full Title: Effect of the GLP-1 analogue liraglutide on intragastric pressure and satiation during nutrient drink infusion. | ||
Medical condition: healthy volunteers no medical condition; drugs will be studied because they are known to influence gastric motility. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001523-31 | Sponsor Protocol Number: U1111-1181-4107 | Start Date*: 2017-01-30 | |||||||||||
Sponsor Name:Steno Diabetes Center Copenhagen | |||||||||||||
Full Title: Effect of liraglutide on vascular inflammation in type-2 diabetes: A randomized, placebo-controlled, double-blind, parallel clinical PET/CT trial | |||||||||||||
Medical condition: Type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005499-16 | Sponsor Protocol Number: 2013-624 | Start Date*: 2014-01-31 | |||||||||||||||||||||
Sponsor Name:Rigshospitalet, 2121 | |||||||||||||||||||||||
Full Title: Pilot Study with Treatment of Short Bowel Syndrome Patients with end-jejunostomi with the Glucagon-Like Peptide-1 analogue, Liraglutide (Victoza®) | |||||||||||||||||||||||
Medical condition: Short Bowel Syndrome with intestinal failure (SBS IF) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000397-19 | Sponsor Protocol Number: Ctrl-DM2 | Start Date*: 2014-09-09 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Effects of Combined Treatment of Surgery and Liraglutide on Glycemic Variability and Control in type 2 Diabetes Mellitus: The Ctrl-DM2 Study | ||
Medical condition: type 2 diabetes with morbid obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020193-42 | Sponsor Protocol Number: 2010-020193-42 | Start Date*: 2010-09-06 |
Sponsor Name:Hywel DdA Health Borad | ||
Full Title: A comparative study of the effects of Liraglutide and Acarbose on glycaemic control, weight and Health-Related Quality-of-life(HRQOL) in Overweight type 2 Diabetic patients on Oral Hypoglycemic Age... | ||
Medical condition: Type-2 Diabetes Mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-000043-31 | Sponsor Protocol Number: 383 | Start Date*: 2020-03-26 |
Sponsor Name:Groupe Hospitalier Paris Saint-Joseph | ||
Full Title: Efficacy and tolerance of Liraglutide for weight loss in obese type 2 diabetic hemodialysis patients | ||
Medical condition: obese type 2 diabetic hemodialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000411-12 | Sponsor Protocol Number: Lir-HJCJ-03 | Start Date*: 2012-03-07 | |||||||||||
Sponsor Name:UMC St Radboud | |||||||||||||
Full Title: The effect of Liraglutide on insulin-associated weight gain in patients with type 2 diabetes | |||||||||||||
Medical condition: patients with type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004481-13 | Sponsor Protocol Number: NN8022-1807 | Start Date*: 2006-10-18 | |||||||||||
Sponsor Name:Novo Nordisk A/S [...] | |||||||||||||
Full Title: Effect of liraglutide on body weight in obese subjects without diabetes A 20-week randomised, double-blind, placebo-controlled, six armed parallel group, multi-centre, multinational trial with an o... | |||||||||||||
Medical condition: obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) CZ (Completed) FI (Completed) DK (Completed) NL (Completed) BE (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001049-24 | Sponsor Protocol Number: NN8022-1839 | Start Date*: 2008-12-02 | ||||||||||||||||
Sponsor Name:Novo Nordisk A/S | ||||||||||||||||||
Full Title: Effect of liraglutide on body weight in non-diabetic obese subjects or overweight subjects with comorbidities A randomised, double-blind, placebo controlled, parallel group, multi-centre, multina... | ||||||||||||||||||
Medical condition: Obesity and overweight Pre-diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IE (Completed) FI (Completed) ES (Completed) DE (Completed) DK (Completed) AT (Completed) GB (Completed) FR (Completed) IT (Completed) NL (Completed) BE (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005163-16 | Sponsor Protocol Number: U1111-1171-4970 | Start Date*: 2016-05-30 | ||||||||||||||||
Sponsor Name:The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark | ||||||||||||||||||
Full Title: Effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis. A randomised, double blind, placebo-controlled, parallel group, single-centre trial | ||||||||||||||||||
Medical condition: Adult (≥ 18 years of age) overweight or obese patients (BMI ≥ 27 kg/m2 ) above 18 years of age with knee osteoarthritis (OA) defined by clinical diagnosis of knee OA according to the American Colle... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004454-34 | Sponsor Protocol Number: NN8022-4181 | Start Date*: 2017-09-13 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of liraglutide in obese children aged 7 to 11 years | |||||||||||||
Medical condition: Obesity | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003572-36 | Sponsor Protocol Number: | Start Date*: 2011-12-05 | |||||||||||
Sponsor Name:Royal Devon & Exeter NHS Foundation Trust [...] | |||||||||||||
Full Title: The role of GLP-1 analogues in reducing reperfusion injury after acute stroke in patients with impaired swallowing. | |||||||||||||
Medical condition: We plan to give a synthetic form of GLP-1 (Liraglutide) that is already available and licensed for use in patients with diabetes in the UK, to patients who have had an acute stroke, in order to det... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021560-15 | Sponsor Protocol Number: NN9068-3697 | Start Date*: 2011-03-22 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A 26 week randomised, parallel three-arm, open-label, multi-centre, multinational treat-to-target trial comparing fixed ratio combination of insulin degludec and liraglutide versus insulin degludec... | |||||||||||||
Medical condition: Type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) IT (Completed) FI (Completed) IE (Completed) SK (Completed) HU (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004415-37 | Sponsor Protocol Number: NN8022-4179 | Start Date*: 2015-11-10 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Effect of liraglutide for weight management in paediatric subjects with Prader-Willi Syndrome. A randomised, placebo controlled, parallel group, multi-centre, multinational trial with a 16-week dou... | |||||||||||||
Medical condition: Obesity (Prader-Willi syndrome) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) FR (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003598-41 | Sponsor Protocol Number: FRDA-GLP1-2014 | Start Date*: 2014-10-02 |
Sponsor Name:CUB - Hôpital Erasme | ||
Full Title: Pilot study of incretin analogs as new therapeutics for Friedreich's Ataxia. | ||
Medical condition: Friedreich's Ataxia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
